MGMT promoter methylation across glioma subtypes: biological relevance, treatment response, and survival outcomes.
- DOI
- 10.1007/s11033-026-12169-z
- Published
- 2026 Jun 18
- Container
- Molecular biology reports
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11033-026-12169-z,
title = {MGMT promoter methylation across glioma subtypes: biological relevance, treatment response, and survival outcomes.},
author = {Sayed U and Alieva R and Hanumanthayya M and Singhal D and Panigrahi R and Tailor NK and Buzrukov T and Norkulov S},
year = {2026},
journal = {Molecular biology reports},
doi = {10.1007/s11033-026-12169-z},
url = {https://doi.org/10.1007/s11033-026-12169-z}
}RIS
TY - JOUR TI - MGMT promoter methylation across glioma subtypes: biological relevance, treatment response, and survival outcomes. AU - Sayed U AU - Alieva R AU - Hanumanthayya M AU - Singhal D AU - Panigrahi R AU - Tailor NK AU - Buzrukov T AU - Norkulov S PY - 2026 JO - Molecular biology reports DO - 10.1007/s11033-026-12169-z UR - https://doi.org/10.1007/s11033-026-12169-z ER -
APA
U, S., R, A., M, H., D, S., R, P., NK, T., T, B., & S, N. (2026). MGMT promoter methylation across glioma subtypes: biological relevance, treatment response, and survival outcomes.. Molecular biology reports. https://doi.org/10.1007/s11033-026-12169-z
Source records
- pubmed · retrieved 2026-09-26T21:50:39.684Z